Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00658021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to test the hypothesis that glycemic control, as measured by change in hemoglobin A1c (HbA1c) from baseline to endpoint, with exenatide is superior to that of placebo after 28 weeks of treatment in adolescent patients with type 2 diabetes who are naïve to antidiabetes agents, or patients who are being treated with metformin, an SU, or a combination of metformin and an SU
Study identification
- NCT ID
- NCT00658021
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 10 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 30, 2008 (Actual)
- Primary completion
- Apr 18, 2019 (Actual)
- Completion
- Apr 1, 2020 (Actual)
- Last update posted
- Dec 1, 2020
2008 – 2020
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35233 | — |
| Research Site | Tucson | Arizona | 85724 | — |
| Research Site | Los Angeles | California | 90048 | — |
| Research Site | Montclair | California | 91763 | — |
| Research Site | Sacramento | California | 95819 | — |
| Research Site | San Diego | California | 92123 | — |
| Research Site | Santa Ana | California | 92707 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Melbourne | Florida | 32901 | — |
| Research Site | Miami | Florida | 33144 | — |
| Research Site | Miami Lakes | Florida | 33014 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Pensacola | Florida | 32504 | — |
| Research Site | Tallahassee | Florida | 32308 | — |
| Research Site | Dalton | Georgia | 30721 | — |
| Research Site | Chicago | Illinois | 60612 | — |
| Research Site | Chicago | Illinois | 60637 | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Wichita | Kansas | 67226 | — |
| Research Site | Dearborn | Michigan | 48124 | — |
| Research Site | Kansas City | Missouri | 64108 | — |
| Research Site | St Louis | Missouri | 63104 | — |
| Research Site | Reno | Nevada | 89502 | — |
| Research Site | Jamaica | New York | 11432 | — |
| Research Site | Greenville | North Carolina | 27834 | — |
| Research Site | Raleigh | North Carolina | 27610 | — |
| Research Site | Oklahoma City | Oklahoma | 73104-5008 | — |
| Research Site | Memphis | Tennessee | 38401 | — |
| Research Site | Dallas | Texas | 75235 | — |
| Research Site | San Antonio | Texas | 78207 | — |
| Research Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00658021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2020 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00658021 live on ClinicalTrials.gov.